Effective inactivated influenza vaccine for the elderly using a single-stranded RNA-based adjuvant

Area of Science:

• Immunology
• Vaccinology
• Gerontology

Background:

• Elderly individuals exhibit diminished vaccine responses, necessitating novel strategies for effective influenza immunization.
• Current inactivated influenza vaccines (IIV) show reduced efficacy in older populations due to immunosenescence.

Purpose of the Study:

• To investigate the potential of single-stranded RNA (ssRNA) as an adjuvant to enhance IIV efficacy in aged mice.
• To evaluate the impact of ssRNA on both cellular and humoral immune responses against influenza in an aging model.

Main Methods:

• Aged mice were immunized with IIV alone or in combination with ssRNA.
• Influenza viral titers, lung pathology, inflammatory markers, antibody (IgA) titers, and T cell responses (IFN-γ) were assessed post-challenge.
• Gene expression analysis was performed to understand the underlying immune mechanisms.

Main Results:

• Co-administration of ssRNA with IIV significantly reduced viral load and lung inflammation in aged mice.
• ssRNA promoted balanced Th1/Th2 immune responses and increased IgA production.
• The ssRNA adjuvant enhanced influenza HA-specific T cell frequency and IFN-γ production, counteracting immunosenescence.

Conclusions:

• Single-stranded RNA (ssRNA) serves as a potent adjuvant, significantly improving the immunogenicity and efficacy of inactivated influenza vaccines in aged mice.
• ssRNA demonstrates potential for overcoming age-related immune decline, offering a promising approach for enhancing influenza vaccine strategies in elderly populations.